<DOC>
	<DOCNO>NCT00002053</DOCNO>
	<brief_summary>To evaluate compare safety , tolerability , efficacy biweekly administration aerosol pentamidine versus placebo use prophylactic agent patient recover first episode AIDS-associated Pneumocystis carinii pneumonia ( PCP ) .</brief_summary>
	<brief_title>A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate Safety Effectiveness Aerosol Pentamidine Prophylaxis Pneumocystis Carinii Pneumonia Patients With AIDS Post First Episode PCP</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Zidovudine ( AZT ) . If AZT start study , patient must receive = &gt; 15 day aerosol pentamidine begin AZT . Prior Medication : Allowed : Zidovudine ( AZT ) . If AZT begin prior study entry , patient must receive = &gt; 15 day AZT begin aerosol pentamidine . Exclusion Criteria Coexisting Condition : Patients follow exclude : Requiring ongoing active therapy opportunistic infection ( O.I . ) time entry either follow AIDSdefining O.I . 's prior entry : Toxoplasmosis . Cryptococcosis . Transfusion dependent ( require blood transfusion per month ) . The last transfusion give within 7 day study entry . Pulmonary Kaposi 's sarcoma ( KS ) . Uncontrolled asthma . Active therapy tuberculosis . Patients follow exclude : Requiring ongoing active therapy opportunistic infection ( O.I . ) time entry either follow AIDSdefining O.I . 's prior entry : Toxoplasmosis . Cryptococcosis . Transfusion dependent ( require blood transfusion per month ) . The last transfusion give within 7 day study entry . Pulmonary Kaposi 's sarcoma ( KS ) . Uncontrolled asthma . Prior Medication : Excluded within 30 day study entry : Antiretroviral agent zidovudine ( AZT ) . Immunomodulating agent . Corticosteroids . Active therapy tuberculosis . Patients must : Have AIDS recover first episode Pneumocystis carinii pneumonia ( PCP ) . Be least 2 week 24 week status post therapy acute PCP . Have positive antibody HIV Governmentapproved ELISA test kit , confirm Western blot test . Adequate pulmonary function ( vital capacity = &gt; 80 percent predict ; force expiratory volume ( FEV ) , 1 = &gt; 65 percent total FEV ; correct pulmonary diffusion capacity &gt; 60 percent predict ) . Free acute medical problem . Active substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 1989</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>